Sartorius AG SARTORIUS PREF SHS
Sartorius AG SARTORIUS PREF SHS/ DE0007165631 /
0NIR
|
24.05.2024 18:35:16
|
Zm.
-
|
Wolumen |
Bid17:40:08 |
Ask17:40:08 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
254,45EUR
|
-
|
11 663
Obrót: 2,46 mln |
-Wolumen Bid: - |
-Wolumen Ask: - |
13,3 mldEUR |
0,34% |
71,77 |
Opis działalności
The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
Zarząd & Rada nadzorcza
| CEO |
| Joachim Kreuzburg |
| Zarząd |
| Rainer Lehmann, Dr. René Fáber, Gerry MacKay, Alexandra Gatzemeyer |
| Rada nadzorcza |
| Dr. Lothar Kappich, Manfred Zaffke, Prof. David Raymond Ebsworth, Dr. Daniela Favoccia, Petra Kirchhoff, Dietmar Müller, Ilke Hildegard Panzer, Frank Riemensperger, Hermann Jens Ritzau, Prof. Dr. Klaus Rüdiger Trützschler, Sabrina Wirth |
Dane firmy
| Nazwa: |
Sartorius AG |
| Adres: |
Otto-Brenner-Str. 20,D-37079 Goettingen |
| Telefon: |
+49-551-308-0 |
| Fax: |
+49-551-308-3289 |
| E-mail: |
info@sartorius.com
|
| Internet: |
www.sartorius.de |
| Przemysł: |
Technologia |
| Sektor: |
Inne branże technologiczne |
| Podsektor: |
- |
| Koniec roku finansowego: |
31.12 |
| Free float: |
40,81% |
| Data IPO: |
10.07.1990 |
Główni akcjonariusze
| FreeFloat |
|
72,00% |
| Bio-Rad Laboratories |
|
28,00% |
